Polystyrene nanoplastics exacerbate aflatoxin B1-induced hepatic injuries by modulating the gut-liver axis

被引:7
作者
Zhang, Kai -Kai [1 ,2 ,3 ,4 ]
Wan, Jia-Yuan [1 ,2 ,3 ,4 ]
Chen, Yu-Chuan [1 ,2 ,3 ,4 ]
Cheng, Chang-Hao [1 ,2 ,3 ,4 ]
Zhou, He-Qi [1 ,2 ,3 ,4 ]
Zheng, De-Kai [1 ,2 ,3 ,4 ]
Lan, Zhi-Xian [1 ,2 ,3 ,4 ]
You, Qiu-Hong [1 ,2 ,3 ,4 ]
Sun, Jian [1 ,2 ,3 ,4 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, State Key Lab Organ Failure Res, Guangzhou 510515, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Minist Educ,Key Lab Infect Dis Res South China, Guangzhou 510515, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangdong Prov Key Lab Viral Hepatitis Res, Guangzhou 510515, Guangdong, Peoples R China
[4] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangdong Prov Clin Res Ctr Viral Hepatitis, Guangzhou 510515, Guangdong, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Polystyrene nanoplastics; Aflatoxin B1; Gut microbiota; Hepatic injuries; Gut -liver axis; IMPACT;
D O I
10.1016/j.scitotenv.2024.173285
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Dietary pollution of Aflatoxin B1 (AFB1) poses a great threat to global food safety, which can result in serious hepatic injuries. Following the widespread use of plastic tableware, co-exposure to microplastics and AFB1 has dramatically increased. However, whether microplastics could exert synergistic effects with AFB1 and amplify its hepatotoxicity, and the underlying mechanisms are still unelucidated. Here, mice were orally exposed to 100 nm polystyrene nanoplastics (NPs) and AFB1 to investigate the influences of NPs on AFB1-induced hepatic injuries. We found that exposure to only NPs or AFB1 resulted in colonic inflammation and the impairment of the intestinal barrier, which was exacerbated by combined exposure to NPs and AFB1. Meanwhile, co-exposure to NPs exacerbated AFB1-induced dysbiosis of gut microbiota and remodeling of the fecal metabolome. Moreover, NPs and AFB1 co-exposure exhibited higher levels of systemic inflammatory factors compared to AFB1 exposure. Additionally, NPs co-exposure further exacerbated AFB1-induced hepatic fibrosis and inflammation, which could be associated with the overactivation of the TLR4/MyD88/NF-kappa B pathway. Notably, Spearman's correlation analysis revealed that the exacerbation of NPs co-exposure was closely associated with microbial dysbiosis. Furthermore, microbiota from NPs-exposed mice (NPsFMT) partly reproduced the exacerbation of NPs on AFB1induced systemic and hepatic inflammation, but not fibrosis. In summary, our findings indicate that gut
引用
收藏
页数:14
相关论文
共 43 条
[31]   Bifidobacterium breve alleviates gut-liver-axis injury caused by high-fat diet and aflatoxin B1 in mice [J].
Ye, Yongli ;
Wang, Tingwei ;
Ji, Jian ;
Wang, Jia-Sheng ;
Zhang, Yinzhi ;
Sun, Xiulan .
FOOD SCIENCE AND HUMAN WELLNESS, 2025, 14 (02)
[32]   Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice [J].
Anhe, Fernando F. ;
Varin, Thibault V. ;
Le Barz, Melanie ;
Pilon, Genevieve ;
Dudonne, Stephanie ;
Trottier, Jocelyn ;
St-Pierre, Philippe ;
Harris, Cory S. ;
Lucas, Michel ;
Lemire, Melanie ;
Dewailly, Eric ;
Barbier, Olivier ;
Desjardins, Yves ;
Roy, Denis ;
Marette, Andre .
DIABETOLOGIA, 2018, 61 (04) :919-931
[33]   Polysaccharide from Salviae miltiorrhizae Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut-Liver Axis [J].
Li, Lixia ;
Lan, Xinting ;
Peng, Xi ;
Shi, Shuai ;
Zhao, Yanlin ;
Liu, Wentao ;
Luo, Qihui ;
Jia, Lanlan ;
Feng, Bin ;
Chen, Zhengli ;
Zou, Yuanfeng ;
Huang, Chao .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
[34]   Protective Effects of Propolis Supplementation on Aflatoxin B1-Induced Oxidative Stress, Antioxidant Status, Intestinal Barrier Damage, and Gut Microbiota in Rats [J].
Kabali, Sevtap ;
Soegut, Mehtap Unlu ;
Oner, Neslihan ;
Kara, Ayca .
MOLECULAR NUTRITION & FOOD RESEARCH, 2025, 69 (10)
[35]   Aflatoxin B1 induces liver injury by disturbing gut microbiota-bile acid-FXR axis in mice [J].
Liu, Yunhuan ;
Li, Jinyan ;
Kang, Weili ;
Liu, Shuiping ;
Liu, Jinyan ;
Shi, Mengdie ;
Wang, Yubo ;
Liu, Xianjiao ;
Chen, Xingxiang ;
Huang, Kehe .
FOOD AND CHEMICAL TOXICOLOGY, 2023, 176
[36]   Lactiplantibacillus plantarum P101-fermented Luffa cylindrica juice alleviate F-53B-induced liver steatosis in mice via the gut-liver axis [J].
Wang, Xinrong ;
Zhao, Tiancheng ;
Zhang, Jinfeng ;
Xu, Hengyi .
FOOD BIOSCIENCE, 2024, 62
[37]   Alpha-aminobutyric acid ameliorates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) progression in mice via enhancing AMPK/SIRT1 pathway and modulating the gut-liver axis [J].
Felicianna ;
Lo, Emily Kwun Kwan ;
Chen, Congjia ;
Ismaiah, Marsena Jasiel ;
Zhang, Fangfei ;
Leung, Hoi Kit Matthew ;
El-Nezami, Hani .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2025, 140
[38]   Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation [J].
Porras, David ;
Nistal, Esther ;
Martinez-Florez, Susana ;
Pisonero-Vaquero, Sandra ;
Luis Olcoz, Jose ;
Jover, Ramiro ;
Gonzalez-Gallego, Javier ;
Victoria Garcia-Mediavilla, Maria ;
Sanchez-Campos, Sonia .
FREE RADICAL BIOLOGY AND MEDICINE, 2017, 102 :188-202
[39]   Combined exposure of nano-titanium dioxide and polystyrene nanoplastics exacerbate oxidative stress-induced liver injury in mice by regulating the Keap-1/Nrf2/ARE pathway [J].
Jia, Tiantian ;
Nie, Penghui ;
Xu, Hengyi .
ENVIRONMENTAL TOXICOLOGY, 2024, 39 (05) :2681-2691
[40]   Cichorium pumilum Jacq Extract Inhibits LPS-Induced Inflammation via MAPK Signaling Pathway and Protects Rats From Hepatic Fibrosis Caused by Abnormalities in the Gut-Liver Axis [J].
Han, Chang ;
Wu, Xi ;
Zou, Nan ;
Zhang, Yunsheng ;
Yuan, Jinqi ;
Gao, Yuefeng ;
Chen, Wen ;
Yao, Jia ;
Li, Cong ;
Hou, Jinqiu ;
Qin, Dongmei .
FRONTIERS IN PHARMACOLOGY, 2021, 12